Literature DB >> 21712541

Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation.

Paolo Santambrogio1, Benedetta Gaia Erba, Alessandro Campanella, Anna Cozzi, Vincenza Causarano, Laura Cremonesi, Anna Gallì, Matteo Giovanni Della Porta, Rosangela Invernizzi, Sonia Levi.   

Abstract

BACKGROUND: Mitochondrial ferritin is a nuclear encoded iron-storage protein localized in mitochondria. It has anti-oxidant properties related to its ferroxidase activity, and it is able to sequester iron avidly into the organelle. The protein has a tissue-specific pattern of expression and is also highly expressed in sideroblasts of patients affected by hereditary sideroblastic anemia and by refractory anemia with ringed sideroblasts. The present study examined whether mitochondrial ferritin has a role in the pathogenesis of these diseases. DESIGN AND METHODS: We analyzed the effect of mitochondrial ferritin over-expression on the JAK2/STAT5 pathway, on iron metabolism and on heme synthesis in erythroleukemic cell lines. Furthermore its effect on apoptosis was evaluated on human erythroid progenitors.
RESULTS: Data revealed that a high level of mitochondrial ferritin reduced reactive oxygen species and Stat5 phosphorylation while promoting mitochondrial iron loading and cytosolic iron starvation. The decline of Stat5 phosphorylation induced a decrease of the level of anti-apoptotic Bcl-xL transcript compared to that in control cells; however, transferrin receptor 1 transcript increased due to the activation of the iron responsive element/iron regulatory protein machinery. Also, high expression of mitochondrial ferritin increased apoptosis, limited heme synthesis and promoted the formation of Perls-positive granules, identified by electron microscopy as iron granules in mitochondria.
CONCLUSIONS: Our results provide evidence suggesting that Stat5-dependent transcriptional regulation is displaced by strong cytosolic iron starvation status induced by mitochondrial ferritin. The protein interferes with JAK2/STAT5 pathways and with the mechanism of mitochondrial iron accumulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21712541      PMCID: PMC3186302          DOI: 10.3324/haematol.2011.042952

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  38 in total

1.  Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis.

Authors:  Guangjun Nie; Alex D Sheftel; Sangwon F Kim; Prem Ponka
Journal:  Blood       Date:  2004-11-02       Impact factor: 22.113

2.  Hematopoietic growth factors signal through the formation of reactive oxygen species.

Authors:  M Sattler; T Winkler; S Verma; C H Byrne; G Shrikhande; R Salgia; J D Griffin
Journal:  Blood       Date:  1999-05-01       Impact factor: 22.113

3.  Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression.

Authors:  Mitsuko Iiyama; Kazuhiko Kakihana; Tetsuya Kurosu; Osamu Miura
Journal:  Cell Signal       Date:  2005-06-27       Impact factor: 4.315

4.  Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.

Authors:  Ramin Tehranchi; Rosangela Invernizzi; Alf Grandien; Boris Zhivotovsky; Bengt Fadeel; Ann-Mari Forsblom; Erica Travaglino; Jan Samuelsson; Robert Hast; Lars Nilsson; Mario Cazzola; Rolf Wibom; Eva Hellström-Lindberg
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

5.  Development of an immunoassay for all human isoferritins, and its application to serum ferritin evaluation.

Authors:  A Cozzi; S Levi; E Bazzigaluppi; G Ruggeri; P Arosio
Journal:  Clin Chim Acta       Date:  1989-10-16       Impact factor: 3.786

6.  Blotting analysis of native IRP1: a novel approach to distinguish the different forms of IRP1 in cells and tissues.

Authors:  Alessandro Campanella; Sonia Levi; Gaetano Cairo; Giorgio Biasiotto; Paolo Arosio
Journal:  Biochemistry       Date:  2004-01-13       Impact factor: 3.162

7.  Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses.

Authors:  S Teglund; C McKay; E Schuetz; J M van Deursen; D Stravopodis; D Wang; M Brown; S Bodner; G Grosveld; J N Ihle
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

8.  Unique iron binding and oxidation properties of human mitochondrial ferritin: a comparative analysis with Human H-chain ferritin.

Authors:  Fadi Bou-Abdallah; Paolo Santambrogio; Sonia Levi; Paolo Arosio; N Dennis Chasteen
Journal:  J Mol Biol       Date:  2005-04-01       Impact factor: 5.469

9.  Crystal structure and biochemical properties of the human mitochondrial ferritin and its mutant Ser144Ala.

Authors:  Béatrice Langlois d'Estaintot; Paolo Santambrogio; Thierry Granier; Bernard Gallois; Jean Marc Chevalier; Gilles Précigoux; Sonia Levi; Paolo Arosio
Journal:  J Mol Biol       Date:  2004-07-02       Impact factor: 5.469

10.  The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast.

Authors:  Alessandro Campanella; Grazia Isaya; Heather A O'Neill; Paolo Santambrogio; Anna Cozzi; Paolo Arosio; Sonia Levi
Journal:  Hum Mol Genet       Date:  2004-07-28       Impact factor: 6.150

View more
  16 in total

1.  A specialized pathway for erythroid iron delivery through lysosomal trafficking of transferrin receptor 2.

Authors:  Shadi Khalil; Maja Holy; Stephen Grado; Robert Fleming; Ryo Kurita; Yukio Nakamura; Adam Goldfarb
Journal:  Blood Adv       Date:  2017-06-27

2.  The iron metallome in eukaryotic organisms.

Authors:  Adrienne C Dlouhy; Caryn E Outten
Journal:  Met Ions Life Sci       Date:  2013

Review 3.  Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia.

Authors:  A Anzovino; D J R Lane; M L-H Huang; D R Richardson
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 4.  Oxidative stress and the homeodynamics of iron metabolism.

Authors:  Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-05-11

5.  Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients.

Authors:  Paolo Santambrogio; Sabrina Dusi; Michela Guaraldo; Luisa Ida Rotundo; Vania Broccoli; Barbara Garavaglia; Valeria Tiranti; Sonia Levi
Journal:  Neurobiol Dis       Date:  2015-03-30       Impact factor: 5.996

6.  Mitochondrial adaptations to oxidative stress confer resistance to apoptosis in lymphoma cells.

Authors:  Sarah T Wilkinson; Margaret E Tome; Margaret M Briehl
Journal:  Int J Mol Sci       Date:  2012-08-16       Impact factor: 6.208

Review 7.  Iron metabolism: current facts and future directions.

Authors:  Leida Tandara; Ilza Salamunic
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

8.  Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity.

Authors:  Federica Maccarinelli; Elena Gammella; Michela Asperti; Maria Regoni; Giorgio Biasiotto; Emilia Turco; Fiorella Altruda; Silvia Lonardi; Laura Cornaghi; Elena Donetti; Stefania Recalcati; Maura Poli; Dario Finazzi; Paolo Arosio; Gaetano Cairo
Journal:  J Mol Med (Berl)       Date:  2014-04-13       Impact factor: 4.599

9.  Differences in vulnerability of neurons and astrocytes to heme oxygenase-1 modulation: Implications for mitochondrial ferritin.

Authors:  Xiaojun Yu; Ning Song; Xinli Guo; Hong Jiang; Haoyun Zhang; Junxia Xie
Journal:  Sci Rep       Date:  2016-04-21       Impact factor: 4.379

10.  Coenzyme A corrects pathological defects in human neurons of PANK2-associated neurodegeneration.

Authors:  Daniel I Orellana; Paolo Santambrogio; Alicia Rubio; Latefa Yekhlef; Cinzia Cancellieri; Sabrina Dusi; Serena G Giannelli; Paola Venco; Pietro G Mazzara; Anna Cozzi; Maurizio Ferrari; Barbara Garavaglia; Stefano Taverna; Valeria Tiranti; Vania Broccoli; Sonia Levi
Journal:  EMBO Mol Med       Date:  2016-10-04       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.